CytomX, Amgen pass on T cell engager; Molecular Partners ends work with Novartis

Plus, news about Atea Phar­ma­ceu­ti­cals:

Cy­tomX, Am­gen stop work on T cell en­gager: The part­ners de­cid­ed to end de­vel­op­ment of an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.